内克塔治疗 | 76.99 +1.28 +1.69% | ||
| NKTR | |||
| 高 78.00 | 开 73.55 | 量 55.29万股 | 总市值 22.09亿 |
| 低 73.04 | 换 1.93% | 额 4204.92万 | 市盈TTM 亏损 |
分时
5日
日K
周K
月K
季K
年K
内克塔治疗(NKTR)
03-27 22:55
$内克塔治疗(NKTR)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000102909-26-001820 Act: 34 Size: 7 KB 网页链接
内克塔治疗(NKTR)
03-14 01:15
$内克塔治疗(NKTR)$ 144 Report of proposed sale of securities Accession Number: 0001959173-26-002286 Act: 33 Size: 5 KB 网页链接
内克塔治疗(NKTR)
03-13 18:36
$内克塔治疗(NKTR)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001193125-26-104547 Act: 34 Size: 16 MB 网页链接
内克塔治疗(NKTR)
03-13 04:55
$内克塔治疗(NKTR)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001213900-26-027026 Act: 34 Size: 300 KB 网页链接
内克塔治疗(NKTR)
03-06 23:15
$内克塔治疗(NKTR)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000315066-26-000649 Act: 34 Size: 11 KB 网页链接
内克塔治疗(NKTR)
02-21 08:15
$内克塔治疗(NKTR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-061885 Size: 6 KB 网页链接
内克塔治疗(NKTR)
02-21 08:15
$内克塔治疗(NKTR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-061886 Size: 5 KB 网页链接
内克塔治疗(NKTR)
02-19 04:55
$内克塔治疗(NKTR)$ 144 Report of proposed sale of securities Accession Number: 0001959173-26-001149 Act: 33 Size: 5 KB 网页链接
内克塔治疗(NKTR)
02-19 04:25
$内克塔治疗(NKTR)$ 144 Report of proposed sale of securities Accession Number: 0001959173-26-001135 Act: 33 Size: 5 KB 网页链接
内克塔治疗(NKTR)
02-14 06:25
$内克塔治疗(NKTR)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001446580-26-000040 Act: 34 Size: 15 KB 网页链接
内克塔治疗(NKTR)
02-13 19:05
$内克塔治疗(NKTR)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-26-049191 Act: 33 Size: 695 KB 网页链接
内克塔治疗(NKTR)
02-13 19:05
$内克塔治疗(NKTR)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001193125-26-049378 Act: 34 Size: 597 KB 网页链接
内克塔治疗(NKTR)
02-11 05:25
$内克塔治疗(NKTR)$ 8-K Current report, item 7.01 Accession Number: 0001193125-26-044751 Act: 34 Size: 131 KB 网页链接
内克塔治疗(NKTR)
02-11 05:25
$内克塔治疗(NKTR)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-26-044760 Act: 33 Size: 553 KB 网页链接
内克塔治疗(NKTR)
02-10 21:15
$内克塔治疗(NKTR)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001193125-26-043755 Act: 34 Size: 5 MB 网页链接
内克塔治疗(NKTR)
01-31 03:25
$内克塔治疗(NKTR)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000102909-26-000212 Act: 34 Size: 7 KB 网页链接
内克塔治疗(NKTR)
01-28 05:05
$内克塔治疗(NKTR)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001213900-26-008210 Act: 34 Size: 187 KB 网页链接
内克塔治疗(NKTR)
01-23 08:35
$内克塔治疗(NKTR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-019843 Size: 5 KB 网页链接
内克塔治疗(NKTR)
01-21 05:25
$内克塔治疗(NKTR)$ 144 Report of proposed sale of securities Accession Number: 0001959173-26-000377 Act: 33 Size: 6 KB 网页链接
内克塔治疗(NKTR)
2025-12-24 07:05
$内克塔治疗(NKTR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-331187 Size: 7 KB 网页链接